C. elegans in high-throughput drug discovery - Test2 - elhamkhani - TriplyDB

C. elegans in high-throughput drug discovery

C. elegans in high-throughput drug discovery

http://www.wikidata.org/entity/Q27027125

about

Discovery and resupply of pharmacologically active plant-derived natural products: A review Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model.Developments in the tools and methodologies of synthetic biology A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models Current approaches for the discovery of drugs that deter substance and drug abuse.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans Direct profiling of the phospholipid composition of adult Caenorhabditis elegans using whole-body imaging mass spectrometry.Transgenerational inheritance of metabolic disease.Caenorhabditis elegans as a model for understanding ROS function in physiology and disease Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans.Worming our way to novel drug discovery with the Caenorhabditis elegans proteostasis network, stress response and insulin-signaling pathways.Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification.Anthelmintic drug discovery: into the future.Microfluidic systems for high-throughput and high-content screening using the nematode Caenorhabditis elegans.A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay.A microfluidic device for automated, high-speed microinjection of Caenorhabditis elegans.The development of high-content screening (HCS) technology and its importance to drug discovery.Automated Wormscan.Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.Drug Discovery in Fish, Flies, and Worms.Cell and small animal models for phenotypic drug discovery.A microfluidic device for efficient chemical testing using Caenorhabditis elegans.Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes.An enhanced C. elegans based platform for toxicity assessment.Targeting the alternative sigma factor RpoN to combat virulence in Pseudomonas aeruginosa Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.High-Throughput, Liquid-Based Genome-Wide RNAi Screening in C. elegans.The lifespan-extending effects of Nymphaea hybrid root extract in the nematode Caenorhabditis elegans.Integrated Microfluidic Device for Drug Studies of Early C. Elegans Embryogenesis.A Systematic Review on Non-mammalian Models in Epilepsy Research.Triggered Drug Release and Enhanced Drug Transport from Ultrasound-Responsive Nanoparticles Identification of small-molecule ion channel modulators in C. elegans channelopathy models

P2860

Q22252341-AA0EBC38-E5AB-4838-837C-70E20F52D387 Q28071846-D2739C1C-EDF9-4DA6-8931-CD9F735C7B4A Q28554683-D3ABA24F-C1F0-488E-B569-027C7D94E8DB Q28651359-B53D923A-35AA-4B96-BB7B-30C5E647000E Q28820987-56614BD0-AEC5-433F-9030-C22BD45CFB2F Q28834438-8F111FDD-AF8B-4675-9389-53072690127E Q28973615-7E626B45-E9DF-475B-978D-DEAE5D3B892D Q33790301-83BE58F8-E10C-4123-813F-176240566CCC Q35465752-11BCD8BC-FDD9-4318-8BB7-D73BA923AB87 Q35756667-110901D2-2C08-4F27-AA2E-52C10D7FB46F Q36225931-488E3D80-BF10-4C2F-8404-8A3D2288C296 Q37638133-24AAC7E3-F877-4A0E-9C75-3379ADF1974F Q38214677-771D4546-0AEE-4E20-91F9-9F4B8197D021 Q38226757-87208036-0665-4840-8646-8FC16F3C0E84 Q38270188-9DFF2310-B035-4A2D-8ABD-9BCAC06689F9 Q38316710-EE13A58C-AFE5-4EA9-8D34-50469149D7FD Q38608835-7EBF6998-A975-4962-86B8-2E4942980476 Q38636067-91C86C09-6BB2-4C5A-BB2C-2890A397E612 Q38654794-5FEF25F2-077A-49F1-A263-EF78B7ACC522 Q38772165-80AA0753-964E-4C0B-B768-2BAC8D401549 Q38834950-8E10EA56-D814-4F26-9594-FC67FC3B4F7E Q38856246-C34F2DCD-9B5D-4F25-A9A0-C3AD2FB5D753 Q39039978-8661F76F-3A98-4429-9138-D499118C32D2 Q39442815-2D1114AA-E897-44CB-9C21-2FA4E8538008 Q41285841-09B41DC9-1CF0-4215-AD03-F6419AE35F1E Q41349411-90E959CB-A253-4418-B4AF-31566157DB0B Q41548039-C08D6F73-3AAF-4BDF-A274-90867ADE6414 Q42282479-DE1DB3D5-F5E3-46A9-80F5-C6831CC1DD89 Q46405748-0159A57F-02E7-414F-BC2C-BE0ABF64F983 Q51829280-BE9FC841-01FD-4C6B-ACF4-70517E27C1DE Q53398723-0444B740-5169-4E6E-B7FB-9DA882F6DB47 Q55012943-B2A4F9F3-40B3-4C46-8AF2-FFC2B4ED6D5E Q55691341-C561B61C-DCD5-4367-87BF-F82F52D7BCAD Q57345703-675ADFB9-7807-4C4B-983D-DB99567019CA Q58695621-C402271A-CE15-4295-8BEB-83F43A0B7E37

P2860

C. elegans in high-throughput drug discovery

http://www.wikidata.org/entity/Q27027125

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

C. elegans in high-throughput drug discovery

@ast

C. elegans in high-throughput drug discovery

@en

C. elegans in high-throughput drug discovery

@nl

type

label

C. elegans in high-throughput drug discovery

@ast

C. elegans in high-throughput drug discovery

@en

C. elegans in high-throughput drug discovery

@nl

prefLabel

C. elegans in high-throughput drug discovery

@ast

C. elegans in high-throughput drug discovery

@en

C. elegans in high-throughput drug discovery

@nl

P1433

Q27027125-136CE70C-AFAF-4457-83BC-21A68577C80E

P1476

Q27027125-443088B4-7A9F-4E57-856D-5CE8FC075D4E

P2093

Q27027125-048496DB-ADC7-422D-8796-CD080527886B

Q27027125-4AC3914D-0331-4073-B7F1-6C6054FE2205

Q27027125-5B63026F-8F2E-431C-9BE9-2EB11B702E51

Q27027125-66A85DB1-2069-4F64-BD80-FE0E3BBEE925

Q27027125-AE0864FF-FC20-4B71-B4F1-069DF3375030

P2860

Q27027125-05BA1870-BCAD-40FA-BE96-A8BAECA697AA

Q27027125-0ABBF7A3-9DBE-4C2A-8A88-EC5BE55F5A5F

Q27027125-0D3E0633-2105-49C9-9BAB-406BEE0D91D6

Q27027125-0E544815-2388-40CB-94C6-4A8D9A8B4113

Q27027125-0FEFEDAD-9E2D-4B3D-BBD7-F49D587DD392

Q27027125-13842AC8-A5B5-4210-97C0-2EF89B4A17E0

Q27027125-1649F74D-5F90-427A-B58B-CDC33995DD34

Q27027125-1C81C2F6-681E-429E-923A-18ADE8A54F9B

Q27027125-24B0A73E-B348-48F7-93F2-761D45F6E5FD

Q27027125-2516699D-5C40-485C-9199-E95534E764BD

P304

Q27027125-83D19BD9-7D01-4326-9FE2-75B080FF1A33

P31

Q27027125-D07E2EC8-6829-49CB-878A-A498CE86D9B1

P356

Q27027125-BBCEECC5-BC3A-470F-B03B-97BC5290A524

P407

Q27027125-B276E235-4AA5-43A3-BF3A-72483E796299

P478

Q27027125-DD4FB71A-6236-41EC-AC16-B0C7151736A8

P577

Q27027125-37037E74-C847-4660-B212-3A80FF2A8DB2

P5875

Q27027125-0C0EFD61-C843-4944-9E5C-A4C33D5E8953

P698

Q27027125-5E304D0E-723B-4A5E-B7ED-ECDC78A5DACC

P921

Q27027125-120DBB57-F2AC-40A7-A399-2FA53A2E0328

Q27027125-AF09A826-E17A-43AC-B0FD-E230E8A0C93E

P932

Q27027125-1421203C-6625-4D7C-A1EF-BB21DED44059

P356

J.ADDR.2013.12.001

P1433

Advanced Drug Delivery Reviews

P1476

C. elegans in high-throughput drug discovery

@en

P2093

Cliff J. Luke

http://www.w3.org/2001/XMLSchema#string

David H. Perlmutter

http://www.w3.org/2001/XMLSchema#string

Gary A. Silverman

http://www.w3.org/2001/XMLSchema#string

Linda P. O'Reilly

http://www.w3.org/2001/XMLSchema#string

Stephen C. Pak

http://www.w3.org/2001/XMLSchema#string

P2860

Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z

Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics

The genetics of Caenorhabditis elegans

The Parallel Worm Tracker: a platform for measuring average speed and drug-induced paralysis in nematodes

Genome sequence of the nematode C. elegans: a platform for investigating biology

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

A C. elegans mutant that lives twice as long as wild type

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms

The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans

A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans

P304

247-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2013.12.001

http://www.w3.org/2001/XMLSchema#string

P407

P478

69-70

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259318791

http://www.w3.org/2001/XMLSchema#string

P698

24333896

http://www.w3.org/2001/XMLSchema#string

P921

Caenorhabditis elegans

P932

4019719

http://www.w3.org/2001/XMLSchema#string